Moderna announced that the Food and Drug Administration (FDA) has postponed the approval of its respiratory syncytial virus (RSV) vaccine until the end of May due to “administrative constraints” within the agency. Originally expected to be decided upon on Sunday, the FDA has not cited any safety, efficacy, or quality concerns regarding the vaccine, as… Continue reading Moderna says FDA delayed RSV vaccine approval to end of May

Novavax announced a significant breakthrough in its partnership with Sanofi, a French pharmaceutical giant, sealing a multibillion-dollar deal to co-commercialize Novavax’s Covid vaccine and to jointly develop combination shots addressing Covid and flu, among other endeavors. The agreement marks a pivotal moment for Novavax, which saw its shares surge by over 130% on Friday. This… Continue reading Novavax shares spike over 100% on Sanofi deal to commercialize Covid vaccine, develop combination shots

The article discusses the challenges and advancements in the availability of weight loss and diabetes medications by pharmaceutical giants Eli Lilly and Novo Nordisk. Eli Lilly’s decision to boost production of its weight loss drug Zepbound and diabetes treatment Mounjaro led to an increase in its full-year revenue outlook by $2 billion, garnering positive reactions… Continue reading Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

AstraZeneca announced its decision to withdraw its Covid-19 vaccine, Vaxzevria, citing a decline in demand as new vaccines targeting specific Covid variants have emerged. Developed in collaboration with the University of Oxford, Vaxzevria was among the first Covid-19 vaccines available globally, with the U.K. initiating its rollout in January 2021. However, the emergence of multiple… Continue reading AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand

Elizabeth Holmes, the former CEO of Theranos, has had her prison sentence reduced, with a current release date of August 16, 2032, according to federal records. This is two years earlier than initially expected, as her previous release date was set for December 29, 2032. Holmes, now 40, entered prison in May 2023 after being… Continue reading Elizabeth Holmes sees more months trimmed from prison release date

Toronto, Ontario – TheNewswire – May 6, 2024 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT); (OTC:VPTDF) has reached another development milestone by submitting its next generation of software, VMS+4.0, to the U.S. Food and Drug Administration (“FDA”). This latest advance of Ventripoint’s AI-powered technology, which rapidly processes ultrasound images of the heart to… Continue reading Ventripoint’s Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration

Amgen’s stock surged over 12% after the pharmaceutical company hinted at positive initial data regarding its experimental weight loss injection, MariTide. This announcement sparked concerns among investors about potential competition in the rapidly expanding weight loss drug market, leading to declines in shares of Novo Nordisk and Eli Lilly. Novo Nordisk, already under pressure due… Continue reading Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

Moderna reported a narrower-than-expected loss for the first quarter, largely attributed to its cost-cutting measures and higher-than-anticipated sales of its Covid vaccine. The biotech company’s revenue for the quarter reached $167 million, with its Covid shot sales dropping approximately 90% from the previous year. Despite this decline, Moderna is gearing up for the potential approval… Continue reading Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold

Pfizer reported robust first-quarter revenue, surpassing expectations and elevating its full-year profit outlook, primarily due to its extensive cost-cutting measures, mitigated drop in Paxlovid sales, and strong performance of non-Covid products. The company revised its adjusted earnings forecast to $2.15 to $2.35 per share, reflecting confidence in its business and cost-reduction initiatives, aiming to achieve… Continue reading Pfizer beats revenue estimates, raises profit outlook on cost cuts and smaller-than-feared drop in Covid drug sales

Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that Duke University Health Center has purchased its second VMS+ unit from Ventripoint , which processes ultrasound images of the heart to generate MRI-quality measurements in minutes. Duke Health Center Arringdon, part of the Duke University Health System located in Durham, North… Continue reading Duke University Health Center — One of America’s Top Heart-care Institutions and Innovators — Purchases Ventripoint’s AI Heart-scan Technology

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) announces further results from the triple negative breast cancer murine model portion of its current research study at Dalhousie University (the “Study”) which confirms that the previously reported tumor volume reduction was due to activation of a tumor specific systemic immune response. These data… Continue reading Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model

The Biden Administration has decided to postpone the planned ban on menthol cigarettes, a move initially proposed by the Food and Drug Administration (FDA) several years ago. Health and Human Services Secretary Xavier Becerra stated that further discussions are necessary, indicating that the process will require more time. The FDA initially announced its intention to… Continue reading Biden administration delays plans to ban menthol cigarettes